Similar Items: Targeted therapies in adolescent and young adult patients with central nervous system tumors
- The future of targeted therapies for pediatric central nervous system tumors
- MEK inhibitors for neurofibromatosis type 1-associated central and peripheral nervous system tumors
- Effects of physical exercise on central nervous system functions: a review of brain region specific adaptations
- Toxic Effects of Excess Vitamins A, B6, and Folic Acid on the Nervous System
- Integrating Molecular Pathology, Tumor Microenvironment, and Novel Therapies to Overcome Resistance in Glioblastoma
- “Don’t Promise Something You can’t Deliver:” Caregivers’ Advice for Improving Services to Adolescents and Young Adults with Autism